Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 3Phase 1 3Phase 2 2Phase 1/2 2Phase NA 1Phase 3 1Phase 2/3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Niacinamide × Clear all
NCT04844528 2025-12-03

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

University of Utah

Phase 2 Recruiting
86 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT03769285 2023-04-06

SPRINTR-Pilot

Women's College Hospital

Phase 2 Unknown
120 enrolled
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡